04.15.16 | Robert H. Resis discusses how petitioners can succeed in biotech/pharma IPRs in Part II of a BNA Patent, Trademark & Copyright Journal series

Robert H. Resis provides useful strategies for petitioners in inter partes review proceedings in biotechnology and pharmaceutical patents in Part II of his two-part series in BNA’s Patent, Trademark and Copryight Journal.

Please click here to read, “A Petitioner’s Guide to Handling IPRs in the Higher-Survival Patent Arena of Biotech and Pharmaceuticals.” A subscription is required.

Please click here for a PDF version.